BIT (ASX) Scripps Research study identifies existing drugs as potential COVID-19 therapies

Originally posted by GiddyYup: ↑

Please don't convince yourself that everybody who raises questions or concerns or who doesn't currently hold shares is making "accusations" or is "working to heap effluent on Biotron's work". You might not like what you read but that doesn't make the questions or discussion any less relevant.

I believe that almost everybody on here wants to see Biotron succeed, myself included. I personally have corrected false statements by some current shareholders who have possibly innocently made false statements and it was only yesterday that I did so reminding people that MM did in fact have a current and significant stake in BIT and that there was no reason to believe that her interests were not aligned with that of shareholders, despite inaccurate claims to the contrary.

I have repeatedly said since May 30 that shareholders should be prepared for a capital raising as the most likely outcome even though some people want to swallow the party line 100% that it can only possibly be non-equity fund raising. This discussion isn't "heaping shite on the company" but engaging in informed discussion about what likely happens from here. Personally as I have said a number of times, I don't think of a capital raising as a bad thing and will finally resolve one of the the big outstanding short term risks for shareholders. Less risk = good.

The fact is most of the false stuff isn't made by non-holders or anybody wanting to see the company fail. Most of the false stuff is made by people who appear to want to shut down conversations because it might scare away innocent newbies who are the ones they are hoping will buy in and drag up the share price. As a person who has been invested in Biotron and many other such stocks discussed on HC over multiple decades I have seen this many times.

If as we hope it can, the company produces a deal or results which will lead to a deal then legitimate discussion about any failings, mis-steps, or things they could have done better along the way isn't going to hold back the incoming tide / flood any more than statements about fake funding options or multiple bidders is currently able to hold back the tide which has been going out.

The truth can be offensive. It can be upsetting. It is often uncomfortable particularly when it doesn't support where we want to be or where we want to see it going. But we don't live in China or other such countries whereby we go to any lengths to conceal the truth and only allow the official story written by the party to be published and discussed. Not liking it doesn't change the fact that it happened and getting upset with those that remember or want to find out what actually happened isn't reasonable.

Any intelligent investor want to know the full picture, warts and all and decide what they want to invest in. The discussion above wouldn't stop me investing in BIT personally but I already know from many years of investing in BIT how many different tries they have had at getting a commercial proposition for BP against various viruses. Thats what makes them high risk / high reward.

You seem to feel that the 8000 or so posts over 168 pages on a thread entitled "$10 billion deal" is all okay because its "the reward" but any discussion which exposes the "risk" should never be spoken of and anybody who does so must be an evil villain. Can you see how this may be a little irrational?

Seriously, at this point what the company needs is a $10 million injection, then on to bigger things. I hope to see this happen in coming weeks then the discussion can move on to HIV results and that long elusive partner to fund phase 3. Only then is it reasonable to even talk about billion dollar deals.

Now step back from the edge and put your toys back in your pram. Nobody here is going to deprive you of the reward if BP comes a knocking and on behalf of all evil villains I hope you make a fortune and that I will see you at the $1 party. Toot toot. All aboard. Not long now.

PS. I'll ask Scoots to draw you a nice picture to cheer you up. It worked for me.

Expand

Don't take it personally. I was not aware that you were an 'evil villain'. (laugh!)
You write very well and it is worth slowing down and appreciating it. A quick scan is a waste.

I agree wholeheartedly about the missed opportunity for capital raising. I was saving my pennies.

Thanks for taking the time. You have certainly cheered me up. You are making a few personal assumptions that miss the mark but not bad all the same. I would like to reply in the same depth but spare time is not currently an asset I own. Not that I would have it any other way in the present moment. Life is good.

No.	Vol.	Price($)
1	100000	1.9¢

No.

Vol.

Price($)

100000

1.9¢

Price($)	Vol.	No.
2.0¢	1202498	5

Price($)

Vol.

No.

2.0¢

1202498

No.	Vol.	Price($)
1	100000	0.019
10	1774771	0.018
10	1139476	0.017
12	3734154	0.016
10	1205000	0.015

No.

Vol.

Price($)

100000

0.019

1774771

0.018

1139476

0.017

3734154

0.016

1205000

0.015

Price($)	Vol.	No.
0.020	1052498	3
0.021	500000	1
0.022	1431102	4
0.023	1100772	2
0.024	153949	2

Price($)

Vol.

No.

0.020

1052498

0.021

500000

0.022

1431102

0.023

1100772

0.024

153949

(20min delay)
Last 1.9¢		Change 0.000(0.00%)		Mkt cap ! $17.14M

Open	High	Low	Value	Volume
1.9¢	1.9¢	1.9¢	$7.664K	403.3K

Scripps Research study identifies existing drugs as potential COVID-19 therapies, page-89

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The market's shrugged at China's stimulus measures all year. Why is this one different?

The winners & losers on market if negative gearing were gone

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

ACCC seeks Olam divestments before it can buy Namoi Cotton

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Scripps Research study identifies existing drugs as potential COVID-19 therapies, page-89

Top Stories

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The market's shrugged at China's stimulus measures all year. Why is this one different?

The winners & losers on market if negative gearing were gone

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

ACCC seeks Olam divestments before it can buy Namoi Cotton

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News